X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3548) 3548
Book Review (556) 556
Publication (50) 50
Book Chapter (13) 13
Conference Proceeding (10) 10
Magazine Article (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2942) 2942
humans (2229) 2229
male (1733) 1733
female (1551) 1551
cyproterone acetate (1306) 1306
animals (962) 962
cyproterone-acetate (838) 838
adult (830) 830
cyproterone - analogs & derivatives (685) 685
cyproterone - pharmacology (654) 654
androgen antagonists - therapeutic use (592) 592
cyproterone - therapeutic use (551) 551
rats (484) 484
middle aged (477) 477
endocrinology & metabolism (444) 444
cyproterone acetate - therapeutic use (412) 412
adolescent (384) 384
prostatic neoplasms - drug therapy (336) 336
obstetrics & gynecology (321) 321
testosterone - blood (312) 312
aged (302) 302
testosterone (287) 287
cyproterone acetate - pharmacology (279) 279
abridged index medicus (277) 277
androgen antagonists - pharmacology (272) 272
hirsutism - drug therapy (270) 270
ethinyl estradiol - therapeutic use (262) 262
testosterone - pharmacology (246) 246
antiandrogens (235) 235
drug therapy, combination (226) 226
cyproterone acetate - administration & dosage (225) 225
time factors (225) 225
women (224) 224
castration (220) 220
acne vulgaris - drug therapy (213) 213
polycystic ovary syndrome - drug therapy (209) 209
treatment outcome (202) 202
mice (197) 197
cyproterone acetate - adverse effects (194) 194
flutamide (194) 194
androgens (185) 185
urology & nephrology (181) 181
drug combinations (179) 179
oncology (178) 178
orchiectomy (176) 176
hirsutism (174) 174
therapy (169) 169
prostate cancer (167) 167
cyproterone - administration & dosage (162) 162
luteinizing hormone - blood (162) 162
androgen antagonists - administration & dosage (157) 157
androgen antagonists - adverse effects (156) 156
dose-response relationship, drug (154) 154
ethinyl estradiol (151) 151
polycystic ovary syndrome (150) 150
pharmacology & pharmacy (148) 148
medroxyprogesterone acetate (147) 147
child (145) 145
ethinyl estradiol - administration & dosage (144) 144
medicine, general & internal (142) 142
prostatic neoplasms - pathology (139) 139
cyproterone - adverse effects (137) 137
estradiol - pharmacology (137) 137
cancer (127) 127
follicle stimulating hormone - blood (127) 127
estrogen (126) 126
prospective studies (125) 125
risk factors (123) 123
dermatology (120) 120
androgen antagonists (119) 119
polycystic ovary syndrome - complications (118) 118
care and treatment (117) 117
pregnancy (117) 117
puberty, precocious - drug therapy (116) 116
insulin resistance (115) 115
reproductive biology (114) 114
testis - drug effects (113) 113
flutamide - pharmacology (112) 112
testosterone - metabolism (112) 112
dihydrotestosterone - pharmacology (111) 111
flutamide - therapeutic use (111) 111
carcinoma (110) 110
clinical trials as topic (108) 108
estradiol (108) 108
prostate - drug effects (108) 108
insulin-resistance (105) 105
organ size - drug effects (104) 104
receptors, androgen - metabolism (104) 104
aged, 80 and over (102) 102
acne (101) 101
polycystic-ovary-syndrome (100) 100
metformin (99) 99
young adult (98) 98
follow-up studies (97) 97
polycystic ovary syndrome - blood (97) 97
toxicology (97) 97
ethinyl estradiol - adverse effects (95) 95
prostatic neoplasms - therapy (95) 95
rats, inbred strains (95) 95
spironolactone (95) 95
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3058) 3058
German (175) 175
French (142) 142
Spanish (39) 39
Italian (34) 34
Japanese (22) 22
Czech (17) 17
Polish (12) 12
Russian (12) 12
Dutch (9) 9
Hungarian (9) 9
Chinese (8) 8
Bulgarian (7) 7
Danish (5) 5
Portuguese (5) 5
Turkish (4) 4
Finnish (2) 2
Norwegian (2) 2
Swedish (2) 2
Croatian (1) 1
Estonian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Neurochirurgica, ISSN 0001-6268, 3/2019, Volume 161, Issue 3, pp. 589 - 592
Cyproterone acetate (CPA) is an antiandrogenic drug which has recently been recognized to promote the occurrence and growth of intracranial meningiomas.... 
Neurology | Surgical Orthopedics | Medicine & Public Health | Hormone therapy | Minimally Invasive Surgery | Neurosurgery | Interventional Radiology | Nomegestrol acetate | Cyproterone acetate | Neuroradiology | Meningioma | REGRESSION | SURGERY | RISK | DISCONTINUATION | CLINICAL NEUROLOGY | Progestin | Case reports | Shrinkage | Acetic acid | Tumors
Journal Article
Environmental Health Perspectives, ISSN 0091-6765, 2006, Volume 114, Issue 1, pp. 134 - 141
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2016, Volume 129, Issue 8, pp. 883 - 890
Background:While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary syndrome (PCOS),comparative data regarding metabolic effects... 
多囊卵巢综合征 | 二甲双胍 | 避孕药 | 随机对照试验 | 生活方式 | 代谢紊乱 | Polycystic ovary syndrome | Metabolic disorder | Combined | Drospirenone | Oral contraceptives | Cyproterone acetate | Polycystic Ovary Syndrome | SYSTEM | METAANALYSIS | NONOBESE WOMEN | ENDOCRINE | ETHINYL-ESTRADIOL | MEDICINE, GENERAL & INTERNAL | DESOGESTREL | Cyproterone Acetate | Metabolic Disorder | INSULIN-RESISTANCE | Oral Contraceptives | CARBOHYDRATE-METABOLISM | GLUCOSE-TOLERANCE | CARDIOVASCULAR RISK-FACTORS | Life Style | Polycystic Ovary Syndrome - blood | Polycystic Ovary Syndrome - metabolism | Prospective Studies | Cyproterone Acetate - administration & dosage | Humans | Carbohydrate Metabolism | Insulin Resistance | Androstenes - administration & dosage | Polycystic Ovary Syndrome - drug therapy | Lipids - blood | Adolescent | Contraceptives, Oral - administration & dosage | Adult | Female | Metformin - administration & dosage | Contraceptives | Stein-Leventhal syndrome | Antiandrogens | Clinical trials | Accountants | Product development | Progesterone | Metformin | Comparative analysis | Acetates | Ovarian cancer | Care and treatment | Dosage and administration | Research | Carbohydrates | Menstruation | Acne | Lipids | Metabolism | Aerobics | Obstetrics | Studies | Birth control | Physical fitness | Weight control | Exercise | Hospitals | Womens health | Insulin resistance | Lifestyles | Diabetes | Index Medicus | Original | Combined; Polycystic Ovary Syndrome | Cyproterone Acetate; Drospirenone; Metabolic Disorder; Oral Contraceptives
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2005, Volume 84, Issue 5, pp. 1375 - 1387
Journal Article
European Journal of Obstetrics and Gynecology, ISSN 0301-2115, 03/2018, Volume 222, pp. 89 - 94
This patient preference prospective study was designed to compare patients' satisfaction in women with endometriosis treated either by an extended-cycle oral... 
Extended-cycle oral contraception | Endometriosis | Hormonal contraception | MANAGEMENT | MEDICAL-TREATMENT | PROGESTOGEN | RECURRENT PELVIC PAIN | CONSERVATIVE SURGERY | OBSTETRICS & GYNECOLOGY | WOMEN | SATISFACTION | REPRODUCTIVE BIOLOGY | CYPROTERONE-ACETATE | QUALITY-OF-LIFE | Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 03/2017, Volume 17, Issue 1, pp. 179 - 179
Background: Virtually all prostate cancer deaths occur due to obtaining the castration-resistant phenotype after prostate cancer cells escaped from apoptosis... 
Castration-resistant prostate cancer | Death receptor 5 | PARP cleavage | TRAIL | DU145 | CHOP | PC-3 | Cyproterone acetate | Apoptosis | Endoplasmic reticulum stress | CARCINOMA-CELLS | MULTICENTER | PROTEIN | MITOCHONDRIA | PHASE-II | OPEN-LABEL | TRIAL | ONCOLOGY | TIGATUZUMAB | RESISTANCE | LIGAND | Index Medicus
Journal Article
Liver International, ISSN 1478-3223, 02/2016, Volume 36, Issue 2, pp. 302 - 310
Journal Article
Journal Article